Implication of microRNAs in the pathogenesis of MDS.

Curr Pharm Des

Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Published: October 2012

MicroRNAs (miRNAs) are significant regulators of human hematopoietic stem cells (HSC), and their deregulation contributes to hematological malignancies. Myelodysplastic syndromes (MDS) represent a spectrum of hematological disorders characterized by dysfunctional HSC, ineffective blood cell production, progressive marrow failure, and an increased risk of developing acute myeloid leukemia (AML). Although miRNAs have been primarily studied in AML, only recently have similar studies been performed on MDS. In this review, we describe the normal function and expression of miRNAs in human HSC, and describe mounting evidence that deregulation of miRNAs contributes to the pathogenesis of MDS.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863958PMC
http://dx.doi.org/10.2174/1381612811209023170DOI Listing

Publication Analysis

Top Keywords

pathogenesis mds
8
implication micrornas
4
micrornas pathogenesis
4
mds
4
mds micrornas
4
mirnas
4
micrornas mirnas
4
mirnas regulators
4
regulators human
4
human hematopoietic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!